Denmark is cutting its forecast for 2025 economic growth by more than half amid weaker prospects for pharmaceutical giant Novo Nordisk A/S, according to government documents seen by Bloomberg News.

Gross domestic product is expected to expand 1.4% this year, down from the government’s May estimate of 3%, the documents showed. The government cited US tariff increases and a weakened outlook for the pharmaceutical industry as drivers for the revision.